Supplementary Figure S1 from Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing

Autor: Chris J.L.M. Meijer, Peter J.F. Snijders, Johannes Berkhof, Dorien Rijkaart, Birgit I. Witte, Sander Van Den Haselkamp, Folkert J. Van Kemenade, Nicole J. Polman, Margot H. Uijterwaal

Supplementary Figure S1. Cumulative incidence curves for CIN3+ of (A) women invited for the first time (29-33 years) and (B) older women (>34 years).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e77221773ebc82f10087a0dd09c1353
https://doi.org/10.1158/1940-6207.22524245

Performance of DNA methylation analysis of ASCL1 , LHX8 , ST6GALNAC5 , GHSR , ZIC1 and SST for the triage of HPV ‐positive women: Results from a Dutch primary HPV ‐based screening cohort

Autor: Renske D.M. Steenbergen, Maaike C G Bleeker, Lisanne Verhoef, Wim Quint, Chris J.L.M. Meijer, Nicole J Polman, Daniëlle A M Heideman, Ruud L.M. Bekkers, Folkert J. van Kemenade, Johannes Berkhof, Anco Molijn, Willem J. G. Melchers

Publikováno v: International Journal of Cancer. 150:440-449

Methylation of host-cell deoxyribonucleic acid (DNA) has been proposed as a promising biomarker for triage of high-risk (hr) human papillomavirus (HPV) positive women at screening. Our study aims to validate recently identified host-cell DNA methylat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::abfbb0e35cce4cd7cb1948ec49965bd3
https://doi.org/10.1002/ijc.33820

Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands

Autor: Nienke J. Veldhuijzen, Chris J.L.M. Meijer, Henrica C.W. de Vet, Nicole J Polman, Leon F.A.G. Massuger, Folkert J. van Kemenade, Yanne de Haan, Johannes Berkhof, Daniëlle A M Heideman

Publikováno v: Preventive Medicine, 125, 5-11. Academic Press Inc.
Preventive Medicine, 125, 5-11
Polman, N J, de Haan, Y, Veldhuijzen, N J, Heideman, D A M, de Vet, H C W, Meijer, C J L M, Massuger, L F A G, van Kemenade, F J & Berkhof, J 2019, ' Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands ', Preventive Medicine, vol. 125, pp. 5-11 . https://doi.org/10.1016/j.ypmed.2019.04.025
Preventive Medicine, 125, pp. 5-11
Preventive Medicine, 125, 5-11. Academic Press

Several countries offer HPV self-sampling for screening non-attendees. It is assumed that screening attendees also prefer self-sampling to clinician-based sampling, however, little research has been conducted with respect to this. Women participating

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::449b610b1cb50603c50ab75b631ecf40
https://pure.eur.nl/en/publications/37c890b9-a818-46f8-bb24-f81b971eaeda

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test

Autor: Daniëlle A M Heideman, Nienke J. Veldhuijzen, Chris J.L.M. Meijer, Nicole J Polman, Peter J.F. Snijders, Johannes Berkhof

Publikováno v: British Journal of Cancer
British Journal of Cancer, 117(10), 1557-1561. Nature Publishing Group
Polman, N J, Veldhuijzen, N J, Heideman, D A M, Snijders, P J F, Meijer, C J L M & Berkhof, J 2017, ' HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test ', British Journal of Cancer, vol. 117, no. 10, pp. 1557-1561 . https://doi.org/10.1038/bjc.2017.309

Background:In human papillomavirus (HPV)-based screening, a repeat HPV test is often recommended for HPV-positive women with normal cytology (HPV-pos/cyt-neg), but its absolute risk of cervical precancer (CIN3+) over two screening rounds needs to be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7564f5f20d4c0920befbc9ba42020f6
https://doi.org/10.1038/bjc.2017.309

Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN

Autor: Renske D.M. Steenbergen, Daniëlle A.M. Heideman, Dorenda K E van Dijken, René H.M. Verheijen, Johan W M Spruijt, Theo J.M. Helmerhorst, Chris J.L.M. Meijer, Johannes Berkhof, Nicole J. Polman, Margot H. Uijterwaal, Folkert J. van Kemenade, Birgit I. Witte, W. Marchien van Baal, Peppino G.C.M. Graziosi, Ruediger Ridder, Peter J.F. Snijders

Publikováno v: International Journal of Cancer. 140:423-430

Women treated for high-grade cervical intraepithelial neoplasia (CIN) are at risk of recurrent CIN Grade 2 or worse (rCIN2+). Currently, posttreatment monitoring is performed using cytology or cytology/high-risk (hr)HPV cotesting. This study aimed to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::da841ccf8ea183b2d34cc8919ef4b961
https://doi.org/10.1002/ijc.30449